4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Miahelsa Holdings Corporation (7129) operates in the Pharmaceutical Retailers industry and is headquartered in Shinjuku, Japan with about 1,838 employees. Its market capitalization is roughly JPY 3 billion. In the fiscal year ended 2026-03-31, 7129 reported JPY 24.9B in revenue and JPY 201M in net income.
Miahelsa Holdings Corporation engages in the pharmaceutical, nursing care, childcare support, or food businesses in Japan. The company operates dispensing pharmacies and provides home infusion therapy services.
Interactive charts & full statements →
| Income statement | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Revenue | JPY 24.9B | JPY 23.8B | JPY 22.7B | JPY 22.2B | — |
| Gross Profit | JPY 2.7B | JPY 2.4B | JPY 2.2B | JPY 2.0B | — |
| Operating Income (EBIT) | JPY 824M | JPY 641M | JPY 395M | JPY 191M | — |
| Net Income | JPY 201M | JPY 300M | JPY 6M | JPY 210M | — |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Dividends Paid | (JPY 84M) | (JPY 77M) | (JPY 75M) | (JPY 75M) | — |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Assets | JPY 15.6B | JPY 13.3B | JPY 13.8B | JPY 14.1B | — |
| Total Liabilities | JPY 11.7B | JPY 9.5B | JPY 10.5B | JPY 10.8B | — |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 7129 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms